We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 663

PBMs are Targets in Nevada’s Diabetes Drug-Pricing Transparency Bill
  • FisherBroyles LLP
  • USA
  • August 1 2017

In the absence of federal action, Nevada, along with a number of other states, is enacting legislation to combat skyrocketing drug prices and create


Is Telemedicine Change Coming to Congress? The Medicare Telehealth Parity Act of 2017 Among Several New Federal Bills
  • Foley & Lardner LLP
  • USA
  • July 10 2017

Congress is reconsidering a nationwide telehealth coverage bill, named the Medicare Telehealth Parity Act of 2017, designed to introduce an


Healthcare Singapore Newsletter - July 2017
  • Baker McKenzie
  • Singapore
  • July 3 2017

On 3 July 2017, the Agency for Care Effectiveness ("ACE") published its inaugural Appropriate Care Guides ("ACG") on "Oral Glucose-Lowering Agents in


Washington Healthcare Update - Jun 26, 2017
  • McGuireWoods LLP
  • USA
  • June 26 2017

House Oversight Committee ranking member Elijah Cummings (D-MD) and Rep. Peter Welch (D-VT), who met with Trump on drug prices in March, say recently


United States ex rel. Phalp
  • Bass, Berry & Sims PLC
  • USA
  • June 26 2017

A unanimous panel of the U.S. Court of Appeals for the Eleventh Circuit (Eleventh Circuit) recently affirmed two grants of summary judgment in favor


Nevada Enacts Transparency Bill Targeting Diabetes Drug Price Increases, Sales Representatives, PBMs, Nonprofit Organizations
  • Cooley LLP
  • USA
  • June 20 2017

As we discussed last week, Nevada’s Governor has signed into law SB 539, which provides sweeping transparency legislation related to several aspects


Reasonable Interpretation of Ambiguous Regulation May Not Preclude False Claims Act Liability
  • Holland & Knight LLP
  • USA
  • June 9 2017

A recent ruling by the U.S. Court of Appeals for the Eleventh Circuit establishes that a defendant in a False Claims Act (FCA) case cannot


CMS Publishes 2016 Hospice Data, Indicating Further ScrutinyChanges
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • May 11 2017

With the publication of the proposed FY 2018 hospice wage index and payment update, CMS indicates further scrutiny and less compensation for hospices


CY 2018 Medicare Advantage Final Call Letter
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • April 27 2017

The most recent MA Call Letter, "Announcement of Calendar Year (CY) 2018 Medicare Advantage Capitation Rates and Medicare Advantage and Part D Payment


Diabetes Not A Disability under the ADA?
  • Sun Life Financial Inc
  • USA
  • February 2 2017

On 13017, a federal judge granted summary judgment to an employer on an ADA discrimination claim on the ground, among others, that the employee's